Pacira BioSciences, Inc. — Director's Dealing 2012

Jun 11, 2012

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Pacira Pharmaceuticals, Inc. (PCRX)
CIK: 0001396814
Period of Report: 2012-06-07

Reporting Person: PATOU GARY (Chief Medical Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2012-06-07	Stock Option (Right to Buy)	$11.68	A	60000	Acquired	2022-06-07	Common Stock (60000)	Direct

Footnotes

F1: 25% of the shares vest on June 7, 2013 and the remainder of the shares vest monthly over the following 36 months.